EMERGENT BIOSOLUTIONS INC (EBS) Stock News

USA - NYSE:EBS - US29089Q1058 - Common Stock

9.4 USD

-0.07 (-0.74%)

Last: 10/29/2025, 5:59:22 PM

10.76 USD

+1.36 (+14.47%)

After Hours: 10/29/2025, 5:59:22 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EBS Latest News, Press Relases and Analysis

All

Press Releases

16 minutes ago - By: Chartmill - Mentions: FMC WOLF CMG SFM ...

News Image

What's going on in today's after hours session

an hour ago - By: Benzinga - Mentions: ALGN GH GKOS NTLA ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 hours ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

2 hours ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

11 hours ago - By: Benzinga - Mentions: CGO ROL ESRT NNBR ...

Earnings Scheduled For October 29, 2025

a day ago - By: Emergent BioSolutions

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

21 days ago - By: Emergent BioSolutions

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

21 days ago - By: Emergent BioSolutions

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

a month ago - By: Stocktwits - Mentions: IWMW AVSU

Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions to Participate in Upcoming Investor Conferences

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions to Participate in Upcoming Investor Conferences

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

3 months ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

3 months ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

3 months ago - By: Yahoo Finance - Mentions: NOW

ServiceNow (NOW) Downgraded Due to Limited Upside Potential

3 months ago - By: Yahoo Finance - Mentions: AMD GEV

Analysts Turn Bullish on AMD — Here’s What’s Powering the Optimism

3 months ago - By: Emergent BioSolutions

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

3 months ago - By: Emergent BioSolutions

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives